These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31244836)

  • 1. Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection.
    Lyski ZL; Messer WB
    Front Immunol; 2019; 10():1276. PubMed ID: 31244836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue.
    Andrade P; Narvekar P; Montoya M; Michlmayr D; Balmaseda A; Coloma J; Harris E
    J Infect Dis; 2020 Jul; 222(4):590-600. PubMed ID: 32193549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.
    Andrade P; Coloma J; Harris E
    Methods Mol Biol; 2018; 1808():151-163. PubMed ID: 29956181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
    Adam A; Woda M; Kounlavouth S; Rothman AL; Jarman RG; Cox JH; Ledgerwood JE; Gromowski GD; Currier JR; Friberg H; Mathew A
    J Immunol; 2018 Dec; 201(12):3804-3814. PubMed ID: 30413671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.
    Michlmayr D; Andrade P; Nascimento EJM; Parker A; Narvekar P; Dean HJ; Harris E
    J Infect Dis; 2021 Feb; 223(2):247-257. PubMed ID: 32572472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.
    Smith SA; de Alwis AR; Kose N; Jadi RS; de Silva AM; Crowe JE
    J Virol; 2014 Nov; 88(21):12233-41. PubMed ID: 25100837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Analysis of B Cell/Antibody Cross-Reactivity Using a Novel Multicolor FluoroSpot Assay.
    Hadjilaou A; Green AM; Coloma J; Harris E
    J Immunol; 2015 Oct; 195(7):3490-6. PubMed ID: 26320246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human antibody response to dengue virus infection.
    Wahala WM; Silva AM
    Viruses; 2011 Dec; 3(12):2374-95. PubMed ID: 22355444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells.
    Friberg H; Jaiswal S; West K; O'Ketch M; Rothman AL; Mathew A
    Viral Immunol; 2012 Oct; 25(5):348-59. PubMed ID: 22934599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures.
    Cox KS; Tang A; Chen Z; Horton MS; Yan H; Wang XM; Dubey SA; DiStefano DJ; Ettenger A; Fong RH; Doranz BJ; Casimiro DR; Vora KA
    MAbs; 2016; 8(1):129-40. PubMed ID: 26491897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the human serum antibody response to secondary dengue virus infections.
    Patel B; Longo P; Miley MJ; Montoya M; Harris E; de Silva AM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005554. PubMed ID: 28505154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell responses during primary and secondary dengue virus infections in humans.
    Mathew A; West K; Kalayanarooj S; Gibbons RV; Srikiatkhachorn A; Green S; Libraty D; Jaiswal S; Rothman AL
    J Infect Dis; 2011 Nov; 204(10):1514-22. PubMed ID: 21930609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika.
    Andrade P; Gimblet-Ochieng C; Modirian F; Collins M; Cárdenas M; Katzelnick LC; Montoya M; Michlmayr D; Kuan G; Balmaseda A; Coloma J; de Silva AM; Harris E
    Nat Commun; 2019 Feb; 10(1):938. PubMed ID: 30808875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.
    Chaudhury S; Gromowski GD; Ripoll DR; Khavrutskii IV; Desai V; Wallqvist A
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005395. PubMed ID: 28222130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.
    de Alwis R; Beltramello M; Messer WB; Sukupolvi-Petty S; Wahala WM; Kraus A; Olivarez NP; Pham Q; Brien JD; Tsai WY; Wang WK; Halstead S; Kliks S; Diamond MS; Baric R; Lanzavecchia A; Sallusto F; de Silva AM
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1188. PubMed ID: 21713020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection.
    Smith SA; Zhou Y; Olivarez NP; Broadwater AH; de Silva AM; Crowe JE
    J Virol; 2012 Mar; 86(5):2665-75. PubMed ID: 22171265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
    Gelanew T; Hunsperger E
    Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.